Phosphorus-Derived Isatin Hydrazones: Synthesis, Structure, Thromboelastography, Antiplatelet, and Anticoagulation...

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Platelet aggregation is a key factor in thrombosis.
• Developing novel anti-aggregant drugs with improved efficacy is crucial.
• Isatin derivatives and organophosphorus compounds have shown biological activity.

Purpose of the Study:

• To synthesize novel isatin hydrazones with phosphorus-containing moieties.
• To evaluate the anti-aggregant and anti-platelet activation properties of these compounds.
• To investigate the structural and stereochemical aspects of the synthesized compounds.

Main Methods:

• Synthesis of isatin hydrazones via reaction of phosphine oxide or phosphinate hydrazides with aryl-substituted isatins.
• Characterization using 31P NMR and X-ray crystallography.
• Evaluation of anti-aggregant activity using acetylsalicylic acid as a reference.
• Assessment of platelet activation inhibition in tissue factor (TF)-activated thromboelastography (TEG) and ex vivo thrombosis models.

Main Results:

• Successful synthesis of new isatin hydrazones containing phosphorus.
• Determination of spatial isomer ratios (1:1 to 1:3) in solution using 31P NMR.
• Confirmation of the predominant Z,syn form in gas, solution, and crystal states via quantum chemical calculations and X-ray analysis.
• Phosphine oxide derivatives and specific phosphinate analogs demonstrated anti-aggregant activity comparable to acetylsalicylic acid.
• The 5-chloro phosphinate derivative showed superior anti-aggregant effects in TF-activated TEG and ex vivo thrombosis models.

Conclusions:

• The synthesized isatin hydrazones possess significant anti-aggregant and anti-platelet activation properties.
• The Z,syn isomer is the predominant and stable form.
• These compounds hold potential for the development of advanced anti-aggregation medications with broad antithrombotic applications.